Trigyn Technologies Limited has filed its quarterly compliance certificate under SEBI regulations for the quarter ended March 31, 2026. The certificate submission, dated April 7, 2026, fulfills the company's regulatory obligations under the Securities and Exchange Board of India framework.

Regulatory Compliance Certificate

The company submitted its certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 to both BSE Limited and National Stock Exchange of India Limited. The certificate was issued by KFin Technologies Limited, which serves as the company's Registrar, Share Transfer and Depository Services agent.

Certificate Confirmation

KFin Technologies Limited, in its confirmation certificate dated May 1, 2026, verified that securities received from depository participants for dematerialisation during the quarter ended March 2026 were properly processed. The registrar confirmed that all securities were appropriately accepted or rejected to the depositories and that the securities comprised in the certificates have been listed on stock exchanges where the earlier issued securities are listed.

The certificate also confirms that security certificates received for dematerialisation have been mutilated and cancelled after due verification by the depository participant. Additionally, the names of the depositories have been substituted in the register of members as the registered owner within the stipulated 21-day period.

Corporate Information

Trigyn Technologies Limited is headquartered at 27 SDF-1, SEEPZ, Andheri (East), Mumbai 400096. The company secretary and compliance officer, Anmol Sanjay Chaturvedi (ACS 73871), signed the regulatory filing. The certificate submission represents part of the company's ongoing compliance with securities market regulations and demonstrates proper adherence to dematerialisation procedures during the reporting quarter.

Trigyn Technologies has announced the resignation of Dr. Satyam Cherukuri as Chairman and Non-Executive Director, effective April 7, 2026. The announcement was made on March 10, 2026, in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Leadership Transition Details

Dr. Satyam Cherukuri (DIN No.: 01294234) has tendered his resignation from his position as Chairman and Non-Executive Director on the Board of Trigyn Technologies Limited. The resignation takes effect from Monday, April 7, 2026, due to personal circumstances requiring his full attention and commitment.

Subsidiary Board Changes

Concurrently with his resignation from the parent company, Dr. Satyam Cherukuri has also stepped down as a Member of the Board of Trigyn Technologies Inc., a subsidiary of the company, with effect from April 7, 2026. This ensures a complete transition from his leadership roles across the corporate structure.

Formal Resignation Communication

In his resignation letter dated March 7, 2026, addressed to the Board members, Dr. Cherukuri stated that personal circumstances now require his full attention and commitment, making him unable to serve Trigyn with the dedication and focus that the role demands. He expressed his commitment to ensuring a smooth and orderly transition of leadership, offering to make himself fully available during the transition period to brief his successor and complete outstanding matters.

Regulatory Compliance Framework

The disclosure was made pursuant to multiple regulatory requirements including Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has provided comprehensive details as required under Regulation 30(6) read with Para A (7) of Part A of Schedule III of the regulations and SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Company Recognition

Trigyn Technologies Limited has placed on record its sincere appreciation for the valuable contributions made by Dr. Satyam Cherukuri during his tenure as Chairman and Non-Executive Director. The company acknowledged his dedication and service in the formal announcement signed by Company Secretary & Compliance Officer Anmol Chaturvedi. Dr. Cherukuri expressed gratitude for the privilege of serving alongside the Board members, carrying with him respect and admiration for their dedication.